Impact of direct-acting antivirals on the burden of HCV infection among persons who inject drugs and men who have sex with men in the Swiss HIV Cohort Study

Abstract

In the Swiss HIV Cohort Study, the number of people who inject drugs with replicating hepatitis C virus (HCV) infection decreased substantially after the introduction of direct-acting antivirals (DAAs). Among men who have sex with men, the increase in DAA uptake and efficacy was counterbalanced by frequent incident HCV infections.